Société canadienne de la sclérose latérale amyotrophique

300 - 265 Yorkland Blvd.
Toronto, Ontario
M2J 1S5
Sigle : SLA Canada
Adresse Internet :

  Projet(s) actif(s)
    Discovery of Therapeutic Targets for FUS-Dependant Forms of ALS.
    Enhancing the efficacy of heat shock protein inducers by cotreatment with a histone deacetylase inhibitor - A therapeutic strategy for ALS
    Targeting SRSF3 to reprogram immune response in ALS